Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | TTR | P02766 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | ELANE | P08246 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | PGR | P06401 | 1/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15164352 | 0.85 | LMNA (0.47) | THRBLMNASMN1; SMN2NPC1RAB9A | |
| SCHEMBL17662334 | 0.83 | LMNA (0.52) | THRBLMNASMN1; SMN2NPC1RAB9A | |
| SCHEMBL3392420 | 0.81 | THRB (0.60) | THRBLMNASMN1; SMN2NPC1RAB9A | |
| SCHEMBL9081470 | 0.80 | LMNA (0.61) | THRBLMNASMN1; SMN2NPC1RAB9A | |
| SCHEMBL9132980 | 0.80 | THRB (0.54) | THRBLMNASMN1; SMN2NPC1RAB9A | |
| SCHEMBL2387797 | 0.80 | LMNA (0.52) | THRBLMNASMN1; SMN2NPC1RAB9A | |
| SCHEMBL5836815 | 0.78 | THRB (0.34) | THRBLMNASMN1; SMN2NPC1RAB9A | |
| SCHEMBL5538274 | 0.78 | LMNA (0.53) | THRBLMNASMN1; SMN2NPC1RAB9A | |
| SCHEMBL23894744 | 0.77 | LMNA (0.57) | THRBLMNASMN1; SMN2NPC1RAB9A | |
| SCHEMBL19543350 | 0.77 | SMN1; SMN2 (0.49) | THRBLMNASMN1; SMN2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100056671-A1 | POLYFUNCTIONAL EPOXY OLIGOMERS | DESIGNER MOLECULES, INC. (US) | 2010-03-04 | — | — | US | claimed |
| WO-2008128209-A1 | POLYFUNCTIONAL EPOXY OLIGOMERS | DESIGNER MOLECULES, INC. (US) | 2008-10-23 | — | — | WO | claimed |
| US-20130299747-A1 | CURATIVES FOR EPOXY COMPOSITIONSERS | DESIGNER MOLECULES, INC. | 2013-11-14 | — | — | US | disclosed |
| US-20130299747-A1 | CURATIVES FOR EPOXY COMPOSITIONSERS | DESIGNER MOLECULES, INC. | 2013-11-14 | — | — | US | disclosed |
| US-20130199724-A1 | CURATIVES FOR EPOXY COMPOSITIONS | DESIGNER MOLECULES, INC. (US) | 2013-08-08 | — | — | US | disclosed |
| US-20130199724-A1 | CURATIVES FOR EPOXY COMPOSITIONS | DESIGNER MOLECULES, INC. (US) | 2013-08-08 | — | — | US | disclosed |
| US-8431655-B2 | Curatives for epoxy compositions | DESIGNER MOLECULES, INC. (US) | 2013-04-30 | — | — | US | disclosed |
| US-8431655-B2 | Curatives for epoxy compositions | DESIGNER MOLECULES, INC. (US) | 2013-04-30 | — | — | US | disclosed |
| US-20100249276-A1 | CURATIVES FOR EPOXY COMPOSITIONS | DESIGNER MOLECULES, INC. (US) | 2010-09-30 | — | — | US | disclosed |
| US-20100249276-A1 | CURATIVES FOR EPOXY COMPOSITIONS | DESIGNER MOLECULES, INC. (US) | 2010-09-30 | — | — | US | disclosed |
| US-20100113643-A1 | CURATIVES FOR EPOXY ADHESIVE COMPOSITIONS | DESIGNER MOLECULES, INC. (US) | 2010-05-06 | — | — | US | disclosed |
| US-20100113643-A1 | CURATIVES FOR EPOXY ADHESIVE COMPOSITIONS | DESIGNER MOLECULES, INC. (US) | 2010-05-06 | — | — | US | disclosed |
| US-20100056671-A1 | POLYFUNCTIONAL EPOXY OLIGOMERS | DESIGNER MOLECULES, INC. (US) | 2010-03-04 | — | — | US | disclosed |
| WO-2008128209-A1 | POLYFUNCTIONAL EPOXY OLIGOMERS | DESIGNER MOLECULES, INC. (US) | 2008-10-23 | — | — | WO | disclosed |
| WO-2008124797-A1 | CURATIVES FOR EPOXY COMPOSITIONS | DESIGNER MOLECULES, INC. (US) | 2008-10-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100249276-A1 | CURATIVES FOR EPOXY COMPOSITIONS | ALOX5, LTC4S, ALOX15B | THRB 4681/4885LMNA 3810/4885SMN1; SMN2 3254/4885 |
| US-20100113643-A1 | CURATIVES FOR EPOXY ADHESIVE COMPOSITIONS | ALOX5, LTC4S, ALOX15B | THRB 4724/4885LMNA 3667/4885SMN1; SMN2 3101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.